European Wax Center filings document the company's public-company transition, including Form 25 removal of its Class A common stock from Nasdaq listing and registration and Form 8-K reports covering the completed merger that made the company a wholly owned subsidiary in the take-private transaction.
The filing record also includes material definitive agreements, capital-structure disclosures, shareholder voting matters, governance updates, and operating and financial results. These disclosures cover EWC Ventures, LLC as an operating subsidiary, merger-related agreements, amended indenture arrangements involving EWC Master Issuer LLC and EWC Sub Issuer LLC, executive changes, and reported results for the waxing-services business.
European Wax Center, Inc. agreed to be taken private by General Atlantic affiliates through a cash merger. Unaffiliated holders of Class A common stock will receive $5.80 per share in cash, while Class B shares will receive $0.00001 per share. The price reflects a 45% premium to the February 9, 2026 closing price and a 51% premium to the 90‑day volume‑weighted average price.
A Special Committee of independent directors and the full board unanimously determined the deal is fair and in the best interests of unaffiliated stockholders. Closing is expected in mid‑2026, subject to approval by unaffiliated stockholders, HSR clearance, and other customary conditions. After completion, the stock will be delisted and the company will become privately held.
European Wax Center, Inc. CEO and director Christopher Daniel Morris reported a Form 4 transaction involving company Class A common stock. On January 8, 2026, 38,546 shares were withheld by the issuer at a price of $3.97 per share to cover his tax withholding obligations tied to the vesting of restricted stock units. After this tax-related share withholding, he beneficially owned 561,454 shares of Class A common stock directly.
European Wax Center, Inc. filed a Form 8-K to report that it issued a press release on January 12, 2026 with commentary regarding its fiscal year ended January 3, 2026. The press release is attached as Exhibit 99.1 and is incorporated by reference into the report.
The company notes that the information provided under Item 2.02 and Item 9.01, as well as Exhibit 99.1, is being furnished rather than filed, meaning it is not subject to certain liability provisions under the Securities Exchange Act and will only be included in other filings if specifically referenced.
European Wax Center, Inc. furnished an 8-K announcing it issued a press release reporting financial results for the 13 and 39 weeks ended October 4, 2025. The press release is included as Exhibit 99.1.
The company states that the information in Items 2.02 and 9.01 and Exhibit 99.1 is being furnished, not filed, under the Exchange Act, and will not be incorporated by reference into Securities Act or Exchange Act filings unless expressly incorporated by specific reference.
European Wax Center (EWCZ) announced a leadership change. Gavin M. O’Connor notified the company on October 14, 2025 of his decision to resign as Chief Administrative Officer, General Counsel and Corporate Secretary to accept a position at another company. His resignation is effective November 7, 2025.
The filing was executed by Chief Financial Officer Thomas Kim. No additional terms or successor details were included in the disclosure.
European Wax Center, Inc. reported that director David P. Berg resigned from its Board of Directors effective immediately on September 10, 2025. The company stated that his resignation was not the result of any disagreement with the company. Following his departure, the Board reduced its size to seven directors, keeping the board structure aligned with its current membership.
Angela Marie Jaskolski, Chief Operating Officer of European Wax Center, Inc. (EWCZ), reported equity awards on 08/18/2025. The filing shows 125,000 restricted stock units granted that vest in four equal annual installments beginning 08/18/2026, subject to continued employment. The filing also reports three option grants totaling 465,000 employee stock options: 195,000 at a $4.66 exercise price, 135,000 at $9.00 and 135,000 at $12.00. These options were granted 08/18/2025 and will become 100% vested and exercisable on 08/18/2029, subject to continued employment, with an expiration date of 08/18/2035. Following the reported transactions, the reporting person beneficially owns 125,000 Class A shares directly and the listed options convertible into 465,000 shares.
European Wax Center, Inc. (EWCZ) Form 3 reports that Angela Marie Jaskolski, Chief Operating Officer and officer reporting person, filed an initial Section 16 Form 3 related to an 08/18/2025 event. The filing states no securities are beneficially owned by the reporting person. The form is signed by an attorney-in-fact on 08/19/2025 and references an Exhibit 24.1 power of attorney.
Kurtis Matthew Smith, Chief Development Officer of European Wax Center, Inc. (EWCZ), reported equity awards granted on 08/14/2025. He received 95,000 restricted stock units (RSUs) that vest in four equal annual installments beginning July 22, 2026, and three employee stock options totaling 350,000 option shares with exercise prices of $4.69, $9.00, and $12.00. The options are exercisable in full on July 22, 2029, and expire on August 14, 2035. The RSUs show $0 purchase price and the options list their exercise prices; after the reported transactions he beneficially owns 95,000 Class A shares and has economic exposure to 350,000 underlying Class A shares via options.
These grants appear structured to provide multi-year retention and alignment with shareholders through time-based vesting and long-dated exercise windows.
Ararat Capital Management, LP, Narrow River Capital Partners Master Fund, L.P., and Raffi Tokatlian report joint beneficial ownership of 2,466,997 shares of European Wax Center, Inc. Class A common stock, representing 5.7% of the class based on 43,339,566 shares outstanding. The filing states the shares are held by the Master Fund and are also attributable indirectly to Ararat as investment manager and to Mr. Tokatlian as the manager of Ararat GP. The reporting persons assert the holdings were not acquired to change or influence control of the issuer.